Shao Meng Wang
Director/Board Member at ASCENTAGE PHARMA GROUP INTERNATIONAL
Profile
Shao Meng Wang was the founder of Oncofusion Therapeutics, Inc. (2012), Ascenta Therapeutics, Inc. (2003), Ascentage Pharma Group Corp.
Ltd.
(2010), and Jiangsu Yasheng Pharmaceutical Development Co. Ltd.
(2009) where he also held the title of Director & Chief Scientific Officer.
Dr. Wang is also the founder of Medsyn Biopharma LLC.
Currently, Dr. Wang holds positions as Non-Executive Director at Ascentage Pharma Group International Co., Ltd.
(2017-present), Director at Oncopia Therapeutics, Inc. (present), Director at Rogel Cancer Center: University of Michigan (present), and Director at Ascentage International Ltd.
(present).
Dr. Wang's former positions include Professor at the University of Michigan, Assistant Professor at Georgetown University, and Editor-in-Chief at the Journal of Medicinal Chemistry.
Dr. Wang received his undergraduate degree from Peking University in 1986 and his doctorate from Case Western Reserve University in 1982.
Shao Meng Wang active positions
| Companies | Position | Start |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Director/Board Member | 2017-11-16 |
Jiangsu Yasheng Pharmaceutical Development Co. Ltd.
 Jiangsu Yasheng Pharmaceutical Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Yasheng Pharmaceutical Development Co. Ltd. develops and produces pharmaceutical products. It focuses on research and development of structure-based molecule for cancer drugs. The company was founded by Dajun Yang, Ming Guo, and Shaomeng Wang in 2009 and is headquartered in Hong Kong. | Founder | 2008-12-31 |
Oncopia Therapeutics, Inc.
 Oncopia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Oncopia Therapeutics LLC engages in biotechnology research. The company was founded in 2017 and is headquartered in Malvern, PA. | Director/Board Member | - |
Rogel Cancer Center: University of Michigan
 Rogel Cancer Center: University of Michigan Medical/Nursing ServicesHealth Services Part of University of Michigan, Rogel Cancer Center provides healthcare services for cancer patients. | Director/Board Member | - |
| Ascentage International Ltd. | Director/Board Member | - |
Former positions of Shao Meng Wang
| Companies | Position | End |
|---|---|---|
| Journal of Medicinal Chemistry | Corporate Officer/Principal | 2020-11-30 |
| Georgetown University | Corporate Officer/Principal | 1999-12-31 |
Ascentage Pharma Group Corp. Ltd.
 Ascentage Pharma Group Corp. Ltd. Pharmaceuticals: MajorHealth Technology Part of Ascentage Pharma Group International Co., Ltd., Ascentage Pharma Group Corp. Ltd. is a Chinese biopharmaceutical company. The company is based in Hong Kong, Hong Kong. The company was founded by Shao Meng Wang. | Founder | - |
Medsyn Biopharma LLC
 Medsyn Biopharma LLC BiotechnologyHealth Technology Medsyn Biopharma LLC develops therapeutics for cancer. The company was founded by Shaomeng Wang and is headquartered in Malvern, PA. | Founder | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Training of Shao Meng Wang
| Peking University | Undergraduate Degree |
| Case Western Reserve University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Health Technology |
| Private companies | 9 |
|---|---|
Oncofusion Therapeutics, Inc.
 Oncofusion Therapeutics, Inc. BiotechnologyHealth Technology Oncofusion Therapeutics, Inc. operates as oncology development company. It specializes in BET Bromodomain Inhibitors, ERG Inhibitors, EZH2-EED Inhibitors and MMSET/NSD2 Inhibitors. The company was founded in 2012 by Arul M. Chinnaiyan and Shaomeng Wang and is headquartered in Ann Arbor, MI. | Health Technology |
Ascenta Therapeutics, Inc.
 Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Health Technology |
Jiangsu Yasheng Pharmaceutical Development Co. Ltd.
Jiangsu Yasheng Pharmaceutical Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Yasheng Pharmaceutical Development Co. Ltd. develops and produces pharmaceutical products. It focuses on research and development of structure-based molecule for cancer drugs. The company was founded by Dajun Yang, Ming Guo, and Shaomeng Wang in 2009 and is headquartered in Hong Kong. | Health Technology |
Oncopia Therapeutics, Inc.
Oncopia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Oncopia Therapeutics LLC engages in biotechnology research. The company was founded in 2017 and is headquartered in Malvern, PA. | Commercial Services |
Medsyn Biopharma LLC
Medsyn Biopharma LLC BiotechnologyHealth Technology Medsyn Biopharma LLC develops therapeutics for cancer. The company was founded by Shaomeng Wang and is headquartered in Malvern, PA. | Health Technology |
Rogel Cancer Center: University of Michigan
Rogel Cancer Center: University of Michigan Medical/Nursing ServicesHealth Services Part of University of Michigan, Rogel Cancer Center provides healthcare services for cancer patients. | Health Services |
| Journal of Medicinal Chemistry | |
| Ascentage International Ltd. | |
Ascentage Pharma Group Corp. Ltd.
Ascentage Pharma Group Corp. Ltd. Pharmaceuticals: MajorHealth Technology Part of Ascentage Pharma Group International Co., Ltd., Ascentage Pharma Group Corp. Ltd. is a Chinese biopharmaceutical company. The company is based in Hong Kong, Hong Kong. The company was founded by Shao Meng Wang. | Health Technology |
- Stock Market
- Insiders
- Shao Meng Wang
